Press Releases and Announcements

Startup Receives $200K Grand Prize to develop Transmembrane Protein Synthesis Platform, a technology that can produce pure protein in hours LOS ANGELES, October 14, 2021... Read More →

 MedTech Innovator announced that Biorithm, Miraquels, Opharmic Technology, and VPIX Medical have been selected as finalists to compete for the title of the 2021 Asia Pacific Grand Prize winner, out of more than 500 applicants. The winning company, which will receive US$175,000, will be determined by virtual audience vote on Wednesday, Oct. 20 during the APACMed MedTech Forum. More than US$100,000 in additional awards will be presented to the finalists.

Grand Prize Competition Set to Take Place on Oct. 14 in Carlsbad, Calif. LOS ANGELES, October 7, 2021 – BioTools Innovator, a new program focused on... Read More →

Startup Receives $350K Grand Prize for Real-Time, Wearable Stroke Monitor for Older Americans Living with High Stroke Risk LOS ANGELES & MINNEAPOLIS–(BUSINESS WIRE)–MedTech Innovator, the... Read More →

PATH EX Wins MedTech Innovator 2021 Execution Award and Receives AdvaMed Accel Virginia Shimer Rybski Memorial Award LOS ANGELES and MINNEAPOLIS, September 23, 2021 – MedTech... Read More →

MedTech Innovator Announces Finalists for $500K 9th Annual Industry Competition Additional five companies selected to compete for 2021 Execution Award LOS ANGELES, September 21, 2021... Read More →

Finalists to Compete in Grand Finals for an Opportunity to Win up to $200,000 in Non-Dilutive Funding LOS ANGELES — July 29, 2021 — BioTools... Read More →

SINGAPORE, 13 July 2021 – Cambridge Consultants part of Capgemini, today announced its collaboration with MedTech Innovator Asia Pacific, the world’s leading non-profit accelerator of medical... Read More →

Finalist Companies Comprised of Promising Entrepreneurs from the Asia Pacific Region LOS ANGELES & SINGAPORE — June 22, 2021 — MedTech Innovator, the largest accelerator... Read More →

2021 Cohort to Prominently Feature the Industry’s Best and Brightest Startups Working to Transform Patient Care Through Innovation LOS ANGELES — June 15, 2021 —... Read More →

Electrophysiology device innovators gain access to pediatric accelerator and will compete in September 2021 final showcase WASHINGTON – (May 18, 2021) – Five finalists have... Read More →

Program to Feature Best-in-Class Early Stage Companies Developing Biotechnology Products, Diagnostic and Drug Discovery Platforms, and Research and Development Services Read More →

Applications open now for May 12 first round pitch event WASHINGTON, March 23, 2021 /PRNewswire/ — Congenital heart disease (CHD) affects six out of 1,000 babies born in... Read More →

Letter from the CEO Signs are pointing to 2021 shaping up to be a GREAT year for medtech. Right out of the gate, CMS granted... Read More →

Letter from the CEO I’d like to remember 2020 as the year of the Breakthrough Device. As 2020 comes to a close, a topic that’s top... Read More →

“The MedTech Innovator Asia Pacific Showcase has demonstrated immense value in facilitating the introduction of the most promising Asia-based startups with potential investors and partners,” said Harjit Gill, CEO of APACMed. “Now in the program’s third year, APACMed is proud to support the team at MedTech Innovator as they aid in the advancement of companies dedicated to improving the standard of care in the Asia Pacific region. We look forward to following this year’s cohort and how each company is working to improve and prolong patient lives through innovation.” Read More →

Applications are reviewed by more than 200 executives and professionals from dozens of leading companies, including manufacturers, providers, and investors such as Johnson & Johnson, RCT Ventures, Baxter, Asahi Intecc, Edwards Lifesciences, Fujikura, NIPRO Medical Corp., Olympus Medical Systems Group, W.L Gore & Associates, Inc., and many more. Read More →

“Being part of the MedTech Innovator Asia Pacific Accelerator program has been a truly rewarding experience – not only because of the lessons we learned and the mentorship we received, but also because of the powerful network we were able to build,” said Dr. Sebastian Bhakdi, Founder and CEO of X-ZELL. Read More →

Based in Germany, cellvie is developing a device-enabled mitochondria transplantation therapy for heart disease. As winners of the Value Award competition, cellvie will receive a $25,000 non-dilutive cash prize and a profile in an upcoming issue of the MedTech Strategist. Read More →

The first-place startup will take home a $150,000 non-dilutive cash prize and the title of APAC MedTech Innovator 2020. The other four finalists will each receive a US$10,000 cash prize. There will also be a SG$30,000 non-dilutive grant awarded by Enterprise Singapore, a one-year residency awarded by JLABS @ Shanghai and the Oliver Healthcare Packaging Sterile Barrier System Design & Development Award. Read More →